Spore.Bio 赌 AI 能在几分钟内读取细菌，而非几天：800万欧元种子轮，2300万美元A轮

做的是什么生意

A Paris deeptech company selling an AI-powered device that detects and identifies bacteria on the factory floor in minutes, for food, beverage, pharmaceutical and cosmetics manufacturers.

启动资金：€8M pre-seed led by LocalGlobe, announced January 2024

起因

Spore.Bio was founded in 2023 in Paris by Amine Raji, a food-manufacturing veteran who had worked at more than 50 factories including for Nestlé; Maxime Mistretta, a microbiologist with a PhD and postdoc from the Pasteur Institute; and Mohamed Tazi, a second-time founder who had sold Gymlib to EGYM. Their bet: machine learning could read the wavelengths of light reflected off a swab and detect, quantify and identify bacteria without culturing them — turning a 5–20 day laboratory process into a minutes-long factory-floor test. The company emerged from stealth in January 2024 with an €8M pre-seed led by LocalGlobe.

经过

Spore.Bio built its first functional device in under eight months, signed commercial contracts and ran an oversubscribed prototype waitlist. In February 2025 it raised a $23M Series A led by Singular — joined by Point 72, Station F and others — to industrialize the process and grow the team toward 50 scientists and engineers. It also partnered with the Pasteur Institute, whose bacterial biobank feeds the AI model. The company cited a global food-testing market of $22.5B in 2023 and average recall costs around $10M.

结果

Still running: as of early 2026 Spore.Bio is commercializing across food, beverages, cosmetics, pharmaceuticals and water, and was named a recipient of Google.org's $20M AI for Science fund in January 2026.

可借鉴之处

一个世纪以来的标准可以被贴近行业的 AI 应用颠覆：光学加上机器学习，创始人要有信誉，把速度作为安全和成本的优势来卖。